GC Biopharma Corp.

KOSE:A006280 Voorraadrapport

Marktkapitalisatie: ₩1.5t

GC Biopharma Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

GC Biopharma heeft een totaal eigen vermogen van ₩1,523.6B en een totale schuld van ₩775.4B, wat de schuld-eigenvermogensverhouding op 50.9% brengt. De totale activa en totale passiva bedragen respectievelijk ₩2,795.3B en ₩1,271.8B. De EBIT GC Biopharma is ₩33.3B waardoor de rentedekking 0.9 is. Het heeft contanten en kortetermijnbeleggingen van ₩46.7B.

Belangrijke informatie

50.9%

Verhouding schuld/eigen vermogen

₩775.39b

Schuld

Rente dekkingsratio0.9x
Contant₩46.67b
Aandelen₩1.52t
Totaal verplichtingen₩1.27t
Totaal activa₩2.80t

Recente financiële gezondheidsupdates

Recent updates

Benign Growth For GC Biopharma Corp. (KRX:006280) Underpins Stock's 25% Plummet

Nov 19
Benign Growth For GC Biopharma Corp. (KRX:006280) Underpins Stock's 25% Plummet

Does This Valuation Of GC Biopharma Corp. (KRX:006280) Imply Investors Are Overpaying?

Nov 07
Does This Valuation Of GC Biopharma Corp. (KRX:006280) Imply Investors Are Overpaying?

Is GC Biopharma (KRX:006280) A Risky Investment?

Oct 17
Is GC Biopharma (KRX:006280) A Risky Investment?

There's No Escaping GC Biopharma Corp.'s (KRX:006280) Muted Revenues

Aug 02
There's No Escaping GC Biopharma Corp.'s (KRX:006280) Muted Revenues

A Look At The Fair Value Of GC Biopharma Corp. (KRX:006280)

Jul 12
A Look At The Fair Value Of GC Biopharma Corp. (KRX:006280)

Is GC Biopharma (KRX:006280) A Risky Investment?

May 25
Is GC Biopharma (KRX:006280) A Risky Investment?

GC Biopharma Corp.'s (KRX:006280) Business And Shares Still Trailing The Industry

Mar 08
GC Biopharma Corp.'s (KRX:006280) Business And Shares Still Trailing The Industry

We Think Green Cross (KRX:006280) Can Stay On Top Of Its Debt

May 02
We Think Green Cross (KRX:006280) Can Stay On Top Of Its Debt

Are Green Cross Corporation's (KRX:006280) Mixed Financials Driving The Negative Sentiment?

Mar 10
Are Green Cross Corporation's (KRX:006280) Mixed Financials Driving The Negative Sentiment?

Shareholders Are Thrilled That The Green Cross (KRX:006280) Share Price Increased 268%

Feb 18
Shareholders Are Thrilled That The Green Cross (KRX:006280) Share Price Increased 268%

Green Cross (KRX:006280) Has A Somewhat Strained Balance Sheet

Jan 31
Green Cross (KRX:006280) Has A Somewhat Strained Balance Sheet

Calculating The Intrinsic Value Of Green Cross Corporation (KRX:006280)

Jan 14
Calculating The Intrinsic Value Of Green Cross Corporation (KRX:006280)

What You Need To Know About Green Cross Corporation's (KRX:006280) Investor Composition

Dec 27
What You Need To Know About Green Cross Corporation's (KRX:006280) Investor Composition

Green Cross Corporation's (KRX:006280) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Dec 09
Green Cross Corporation's (KRX:006280) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Does Green Cross's (KRX:006280) Statutory Profit Adequately Reflect Its Underlying Profit?

Nov 21
Does Green Cross's (KRX:006280) Statutory Profit Adequately Reflect Its Underlying Profit?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ₩1,223.2B ) A006280 } overtreffen de korte termijn passiva ( ₩791.1B ).

Langlopende schulden: De kortetermijnactiva A006280 ( ₩1,223.2B ) overtreffen de langetermijnschulden ( ₩480.6B ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 47.8% ) A006280 wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van A006280 is de afgelopen 5 jaar gestegen van 38.4% naar 50.9%.

Schuldendekking: De operationele kasstroom van A006280 is negatief, waardoor de schuld niet goed gedekt is.

Rentedekking: De rentebetalingen van A006280 op haar schulden worden niet goed gedekt door EBIT ( 0.9 x dekking).


Balans


Ontdek gezonde bedrijven